Amphetamine Tablet, Orally Disintegrating
Product Images NDC 0480-3316

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amphetamine (NDC 0480-3316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure of amphetamine showing a benzene ring attached to a carbon chain with an amine group. The molecular formula C9H13N and molecular weight 135.21 are displayed below the structure.*

FDA Label Image

1 (Image 2)

A pharmacokinetic graph showing the mean concentration (ng/mL) of Dextroamphetamine and Levoamphetamine over time (hours) after administration of Amphetamine ER orally disintegrating tablets (ER ODT) and MAS ER formulations. The graph compares concentration levels up to 60 hours post-dose.*

FDA Label Image

1 (Image 3)

Amphetamine Extended-Release 3.1 mg orally disintegrating tablets packaging label showing a 30-count bottle of unit-dose tablets. Label includes warnings not to crush or chew tablets and directs pharmacists to dispense the accompanying medication guide. Manufactured by Teva Pharmaceuticals, the label features the product name, strength, dosage form, quantity, and regulatory information including the NDC number 0480-3315-65.*

FDA Label Image

1 (Image 4)

Packaging label for Amphetamine Extended-Release Orally Disintegrating Tablets, 6.3 mg strength. The box contains 30 unit-dose tablets (5 strips of 6 tablets), labeled for oral use and extended-release formulation. The labeler is Teva Pharmaceuticals, with instructions not to crush or chew the tablets and a note for pharmacists to dispense the accompanying Medication Guide.*

FDA Label Image

1 (Image 5)

Packaging label for Amphetamine Extended-Release 9.4 mg orally disintegrating tablets by Teva Pharmaceuticals, Inc. The label shows the product name, strength, dosage form, quantity (30 unit-dose tablets), and instructions not to crush or chew the tablets. The label includes the NDC 0480-3317-65 and the Teva logo.*

FDA Label Image

1 (Image 6)

The image shows a flattened carton for Amphetamine Extended-Release Orally Disintegrating Tablets, 12.5 mg strength. The packaging is labeled for Rx only, containing 30 (5 x 6) unit-dose tablets. It includes warnings not to crush or chew tablets and instructs pharmacists to dispense the medication guide. The labeler is Teva Pharmaceuticals, Inc. The packaging features the Teva logo and standard regulatory and storage information.*

FDA Label Image

1 (Image 7)

Amphetamine Extended-Release 15.7 mg orally disintegrating tablets packaging carton from Teva Pharmaceuticals, Inc. The label states 'Do not crush or chew tablets' and includes medication guide instruction for pharmacists. The carton contains 30 unit-dose tablets, arranged as 5 blister packs of 6 tablets each. The design features the Teva logo and uses green and black text on a white background.*

FDA Label Image

1 (Image 8)

Packaging label for Amphetamine Extended-Release Orally Disintegrating Tablets, 18.8 mg strength, from Teva Pharmaceuticals, Inc. The label indicates a 30 count (5 x 6) unit-dose tablet package. It includes instructions not to crush or chew tablets and notes that a Medication Guide should be dispensed to each patient. The design features the Teva logo and a green accent swoosh.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.